Polysaccharide nanoparticles: From fabrication to applications

A Plucinski, Z Lyu, BVKJ Schmidt - Journal of Materials Chemistry B, 2021 - pubs.rsc.org
Polysaccharides have attracted considerable attention in a broad range of applications in
recent years, which is due to their remarkable features such as biocompatibility …

Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system

G Huang, H Huang - Journal of Controlled Release, 2018 - Elsevier
Hyaluronic acid (HA) is a natural polysaccharide with good biocompatibility and
degradability. HA and its derivatives can be used as sustained-release carriers for drugs …

Recent advances in hyaluronic acid-based nanomedicines: Preparation and application in cancer therapy

X Hou, D Zhong, H Chen, Z Gu, Q Gong, X Ma… - Carbohydrate …, 2022 - Elsevier
Rapid development of stimuli-responsive drug delivery systems (DDSs) for tumor therapy
has raised increasing interest in recent decades, and many nanomedicines are prepared to …

Bio-based nanomaterials for cancer therapy

Y Li, X Zheng, Q Chu - Nano Today, 2021 - Elsevier
Bio-based nanomaterials have received considerable attention in cancer therapies due to
their potent characteristics such as autologous pharmaceutical, synergetic effects …

Hyaluronic acid-based nanomaterials for cancer therapy

JH Kim, MJ Moon, DY Kim, SH Heo, YY Jeong - Polymers, 2018 - mdpi.com
Hyaluronic acid (HA) is a nonsulfated glycosaminoglycan and a major component of the
extracellular matrix. HA is overexpressed by numerous tumor cells, especially tumor …

Innovative nano-carriers in anticancer drug delivery-a comprehensive review

P Dong, KP Rakesh, HM Manukumar… - Bioorganic …, 2019 - Elsevier
In the scientific field, nanotechnology has offered multipurpose and designated functional
nanoparticles (NPs) for the development of applications in nano-medicine. This present …

Nanoparticle‐based nanomedicines to promote cancer immunotherapy: recent advances and future directions

J Liu, R Zhang, ZP Xu - Small, 2019 - Wiley Online Library
Cancer immunotherapy is a promising cancer terminator by directing the patient's own
immune system in the fight against this challenging disorder. Despite the monumental …

Role of cell surface proteoglycans in cancer immunotherapy

NA Espinoza-Sánchez, M Götte - Seminars in cancer biology, 2020 - Elsevier
Over the past few decades, understanding how tumor cells evade the immune system and
their communication with their tumor microenvironment, has been the subject of intense …

Improving cancer immunotherapy outcomes using biomaterials

S Yan, Z Luo, Z Li, Y Wang, J Tao, C Gong… - Angewandte …, 2020 - Wiley Online Library
Immunotherapy has made great strides in improving clinical outcomes in cancer treatment.
However, few patients exhibit adequate response rates for key outcome measures and …

DePEGylation strategies to increase cancer nanomedicine efficacy

L Kong, F Campbell, A Kros - Nanoscale horizons, 2019 - pubs.rsc.org
To maximize drug targeting to solid tumors, cancer nanomedicines with prolonged
circulation times are required. To this end, poly (ethylene glycol)(PEG) has been widely …